Expanding Capacity to Treat Hepatitis C: Overcoming Barriers and New Innovations Joseph K. Lim Invited Commentary 17 April 2018 Pages: 83 - 87
Nutritional Assessment and Management for Hospitalized Patients with Cirrhosis Barbara LattanziDaria D’AmbrosioManuela Merli Management of Cirrhotic Patient (A Cardenas and P Tandon, Section Editors) 27 March 2018 Pages: 88 - 96
The Newest Direct-Acting Antiviral Agents: the Final Chapter in DAA Development Marwa IsmailJordan J. Feld Hepatitis C (A Aronsohn and H Vargas, Section Editors) 07 April 2018 Pages: 97 - 104
Hepatitis C Virus Treatment in Non-Liver Organ Transplantation Programs Eduardo A. RodriguezBashar A. Aqel Hepatitis C (A Aronsohn and H Vargas, Section Editors) 05 April 2018 Pages: 105 - 110
Strategies for the Elimination of Hepatitis C Virus Infection as a Public Health Threat in the United States Charitha GowdaVincent Lo Re III Hepatitis C (A Aronsohn and H Vargas, Section Editors) 24 March 2018 Pages: 111 - 120
Treatment of DAA-Experienced Patients with Chronic Hepatitis C Maria A. CorcorranJohn D. Scott Hepatitis C (A Aronsohn and H Vargas, Section Editors) 24 March 2018 Pages: 121 - 129
Extrahepatic Malignancies in Primary Biliary Cholangitis Annarosa FloreaniMaria Francesca Secchi Autoimmune, Cholestatic, and Biliary Diseases (S Gordon and C Bowlus, Section Editors) 20 March 2018 Pages: 130 - 134
Ethnic and Racial Differences in Autoimmune Liver Diseases Arnaldo FreireCynthia Levy Autoimmune, Cholestatic, and Biliary Diseases (S Gordon and C Bowlus, Section Editors) 26 April 2018 Pages: 135 - 142
Therapeutics for Pruritus in Cholestatic Liver Disease: Many Treatments but Few Cures Mark PedersonMarlyn J. Mayo Autoimmune, Cholestatic, and Biliary Diseases (S Gordon and C Bowlus, Section Editors) 06 April 2018 Pages: 143 - 151